Diagnostic Standards for Dopaminergic Augmentation of Restless Legs Syndrome: Report from a World Association of Sleep Medicine – International Restless Legs Syndrome Study Group Consensus Conference at the Max Planck Institute

García-Borreguero, Diego; Allen, Richard P.; Kohnen, Ralf; Högl, Birgit; Trenkwalder, Claudia; Oertel, Wolfgang; Hening, Wayne A.; Paulus, Walter; Rye, David; Walters, Arthur; Winkelmann, Juliane; On behalf of the International Restless Legs Syndrome Study Group (IRLSSG),

doi:10.1016/j.sleep.2007.03.022

« Previous Next »Sleep Medicine
Volume 8, Issue 5 , Pages 520-530, August 2007

Diagnostic Standards for Dopaminergic Augmentation of Restless Legs Syndrome: Report from a World Association of Sleep Medicine – International Restless Legs Syndrome Study Group Consensus Conference at the Max Planck Institute

Diego García-Borreguero
- Sleep Research Institute, Alberto Alcocer 19, 28036 Madrid, Spain
- Corresponding author. Tel.: +34 913 454 129; fax: +34 913 459 095.
Richard P. Allen
- Department of Neurology, Johns Hopkins University, Baltimore, MD, USA
Ralf Kohnen
- IMEREM GmbH, Nürnberg, Germany
Birgit Högl
- Department of Neurology, University of Innsbruck, Austria
Claudia Trenkwalder
- Paracelsus-Elena Klinik, Kassel, Germany
Wolfgang Oertel
- Department of Neurology, University of Marburg, Germany
Wayne A. Hening
- UMDNJ-RW Johnson Medical School, New Brunswick, NJ, USA
Walter Paulus
- Department of Clinical Neurophysiology, University of Göttingen, Germany
David Rye
- Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA
Arthur Walters
- New Jersey Neuroscience Institute at JFK Medical Center, Seton Hall University School of Graduate Medical Education, Edison, NJ, USA
Juliane Winkelmann
- Max Planck Institute of Psychiatry and Institute for Human Genetics, GSF National Research Center for Environment and Health, Munich, Germany
On behalf of the International Restless Legs Syndrome Study Group (IRLSSG)
- Augmentation Study Group (further participants in alphabetical order): P.C. Baier (Kiel, Germany), H. Benes (Schwerin, Germany), S. Chokroverty (New Jersey, USA), A. De Weerd (Zwolle, Netherlands), C. Earley (Baltimore, USA), L. Ferini-Strambi (Milan, Italy), I. Fietze (Berlin, Germany), S. Fulda (Munich, Germany), V. Gschliesser (Innsbruck, Austria), G. Hadjigeorgiou (Larissa, Greece), S. Happe (Bremen, Germany), M. Hornyak (Freiburg, Germany), D. Kaynak (Istanbul, Turkey), R. Poryazova (Zurich, Switzerland), L. Rijsman (The Hague, The Netherlands), M.C. Rodriguez Oroz (Pamplona, Spain), K. Stiasny-Kolster (Marburg, Germany), W. Zieglgänsberger (Munich, Germany), M. Zucconi (Milan, Italy).

Received 27 January 2007; received in revised form 6 March 2007; accepted 17 March 2007.

To access this article, please choose from the options below

PII: S1389-9457(07)00138-4

doi:10.1016/j.sleep.2007.03.022

Refers to erratum:

Erratum to “Diagnostic standards for dopaminergic augmentation of restless legs syndrome: Report from a World Association of Sleep Medicine – International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute” [Sleep Med. 8 (2007) 520–530]
Diego García-Borreguero, Richard P. Allen, Ralf Kohnen, Birgit Högl, Claudia Trenkwalder, Wolfgang Oertel, Wayne A. Hening, Walter Paulus, David Rye, Arthur Walters, Juliane Winkelmann, Christopher J. Earley, On behalf of the International Restless Legs Syndrome Study Group (IRLSSG)
Sleep Medicine November 2007 (Vol. 8, Issue 7, Page 788)
- Full Text
- PDF (52 KB)